Skip to Content

NVR ABL (Tasigna 50 mg)

Generic Name: nilotinib

Pill with imprint NVR ABL is Red & Yellow, Capsule-shape and has been identified as Tasigna 50 mg.

Tasigna is used in the treatment of chronic myelogenous leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Tasigna 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NVR ABL

Tasigna 50 mg NVR ABL

Tasigna

Generic Name
nilotinib
Imprint
NVR ABL
Strength
50 mg
Color
Red & Yellow
Size
12.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Manufacturer
Novartis Pharmaceuticals
National Drug Code (NDC)
00078-0951
Inactive Ingredients
silicon dioxide, crospovidone, lactose monohydrate, magnesium stearate, poloxamer 188, gelatin, ferric oxide red, ferric oxide yellow, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.